Σύμφωνα με τα κριτήρια της UEMS - EACCME χορηγούνται 16 μόρια Συνεχιζόμενης Ιατρικής Εκπαίδευσης (CME-CPD credits)
Friday, January 13, 2023
| 16.30 - 17.00 | Εισαγωγή • Introduction G. Mantzaris |
| 17:00 - 18.30 |
Diagnostic Modalities with Clinical Applications Chair: M. Tzouvala, S. Potamianos |
| 17:00-17:15 | Crohn’s Disease Capsule Endoscopy N. Viazis |
| 17:15-17:30 | Intestinal US G. Fiorino  |
| 17:30-17:45 | Confocal endomicroscopy: where do we stand? R. Atreya  |
| 17:45-18:00 | Can we harvest new bio-markers in the microbiome? F. Magro  |
| 18:00-18:15 | Application of artificial Intelligence in the field of IBD U. Kopylov  |
| 18:15-18:30 | Discussion |
| 18:30 - 18:50 | State of the art lecture Chair: G. Bamias, N. Viazis |
| TDM for biologic therapy in IBD: A Journey from the Dept of Gastroenterology, Evangelismos Hospital to Leuven and Harvard K. Papamichail  |
| 18:50- 20:00 | ΕΝΑΡΚΤΗΡΙΑ ΤΕΛΕΤΗ • OPENING CEREMONY |
| 18:50-19.05 | Χαιρετισμοί – Welcome Messages |
| 19:05-20:00 |
Η ΕΟΜΙΦΝΕ τιμά τον Γεράσιμο Μάντζαρη/ The Hellenic Society for the study of IBD honours Dr. Gerassimos Mantzaris |
|
Gerassimos Mantzaris: a journey of challenges and achievements through life and medicine |
|
| A short review of the history of IBD G. Mantzaris |
| 20:00 | Welcome Reception/ Cocktail |
Saturday, January 14, 2023
| 09:00 - 10:30 |
A Critical Review of the Past and Present Immunomodulating and Biologic Treatments: where do we stand today? Chair: D. Christodoulou, D. Karagiannis |
| 09:00-09:15 | Thiopurines P. Gionchetti |
| 09:15-09:30 | Anti-TNFα G. Van Assche  |
| 09:30-09:45 | Anti-integrins R. Eliakim |
| 09:45-10:00 | Leukocytapheresis E. Domènech  |
| 10:00-10:15 | Anti-IL12/IL23/p40 M. Allez  |
| 10:15-10:30 | Discussion |
| 10.30 - 11:00 |
State of the Art Lecture Chair: O. Giouleme, S. Manolakopoulos |
| Pouch related pathology: treatment and lessons on IBD I. Dotan |
| 11:00 - 11:30 | Διάλειμμα καφέ/ Coffee break |
| 11.30 - 13:30 | Novel biologics, small molecules, and future therapies: Great Expectations, or? Chair: E. Zampeli, G. Michalopoulos |
| 11:30-11:50 | Αnti-IL23/p19 S. Ben Horin |
| 11:50-12:10 | SP1 modulators J. Lindsay  |
| 12:10-12:30 | Pan-JAK/JAK-1 inhibitors B. Siegmund |
| 12:30-12:50 | Targeting the microbiome P. Seksik |
| 12:50-13:10 | Can we restore intestinal damage G. Bamias |
| 13:10-13:30 | Discussion |
| 13:30 - 14:30 | State of the Art Lecture New therapeutic strategies and new end-points in RCTs Chair: K. Karmiris, D. Polymeros |
| 13:30-14:00 | Determining Therapeutic Goals for Treat-to-Target strategies in IBD: What new goals does STRIDE II bring? A. Dignass |
| 14:00-14:30 | A critical analysis of the IOIBD proposed new end-points for Disease Modifying Trials in IBD G. Rogler  |
| 14:30 - 15:30 | Ελαφρύ Γεύμα/ Light Lunch |
| 15.30 - 16.00 | State of the Art Lecture Chair: M. Kontogianni, M. Gazouli |
| Microbiota-targeted dietary interventions in IBD patients L. Godny |
| 16.00 - 16:30 | State of the Art Lecture Chair: S. Michopoulos, A. Theodoropoulou |
| Therapeutic strategies for the prevention of post-operative recurrence of Crohn’s disease M. Allez |
| 16:30 - 18:00 |
Case-based discussion Ι: short cases – short answers/comments Chair: G. Bamias, I. Papakonstantinou , M. Allez , Gert Van Assche , S. Ben Horin , I. Dotan , G. Fiorino , B. Siegmund , Κ. Papamichail |
|
→ IFX-rescue therapy for iv steroid-refractory UC patient. Empirical? Accelerated? Proactive TDM? → Monitoring the CD patient on maintenance anti-TNF therapy: biomarkers or Proactive TDM? → Novel combination therapies: which? for whom? when? → My chosen biologic MoA: when effectiveness matters/when safety matters → When and how can I stop biologic therapy? → Early surgery or medical therapy for limited terminal ileitis/ ielocolitis? |
| 18:00- 18:15 | Διάλειμμα καφέ/ Coffee break |
| 18:15 - 19:30 |
Case-based discussion ΙI: short cases – short answers/comments Chair: I. Koutroubakis, K. Katsanos , A. Dignass , A. Eliakim , P. Gionchetti , J. Lindsay , F. Magro , G. Rogler
|
|
→ Should I strive for Endoscopic or Transmural healing in Crohn disease? → Can I tolerate near complete endoscopic healing in CD? → Is histologic healing in CD cost-effective? and if yes, how to assess? → Endoscopic healing in UC: Mayo 0 or Mayo 1? → Should I strive for histologic remission in UC? → Can the current therapies achieve these robust end points? What are the unmet needs → How to incorporate patients views in end-points for RCTs and in real-life practice? |
| 19:30 - 20:00 |
Discussion with the Mentors Chair: G. Mantzaris, I. Koutroubakis, I. Triantafyllidis |
Sunday, January 15, 2023
| 09:00 - 09:45 |
Νέα δεδομένα για τη θεραπεία λοιμώξεων στις ΙΦΝΕ/ Update in the management of infections in IBD Προεδρείο: Β. Παπασταμόπουλος, Ι. Βλαχογιαννάκος/ Chairs: V. Papastamopoulos, I. Vlachogiannakos |
| 09:00-09:15 |
C. difficile |
| 09:15-09:30 |
CMV |
| 09:30-09:45 |
COVID-19 |
| 09:45 - 10:45 |
Εξωεντερικές εκδηλώσεις στις ΙΦΝΕ. Red Flags!/ Extraintestinal manifestations in IBD: Red flags! Προεδρείο: Γ. Παπαθεοδωρίδης, Ε. Τσιρώνη/ Chairs: G. Papatheodoridis, E. Tsironi |
| 09:45-10:00 |
Πότε θα χρειαστώ Ρευματολόγο;/ When do I need a Rheumatologist? |
| 10:00-10:15 |
Πότε θα χρειαστώ Δερματολόγο;/ When do I need a Dermatologist? |
| 10:15-10:30 |
Πότε θα χρειαστώ Οφθαλμίατρο;/ When do I need an Ophthalmologist? |
| 10:30-10:45 |
Πώς θα αντιμετωπίσω τις παράδοξες φλεγμονές;/ How should I manage paradoxical inflammation? |
| 10:45 - 11:15 | Διάλειμμα καφέ/ Coffee break |
| 11:15 - 12:15 | State of the Art Lectures Chair: D. Magganas, E. Archavlis |
| 11:15-11:45 | Perianal fistulizing Crohn’s disease: to drain, to seton, to LIFT, to plug, or to cut? I. Papaconstantinou |
| 11:45-12:15 | The role of surgery in IBD today and tomorrow A. D'Hoore |
| 12.15 - 13.15 |
Ηωσινοφιλική Οισοφαγίτιδα/ Eosinophilic oesophagiotis Προεδρείο: Α. Μαντίδης, Ε. Τσουκάλη/ Chairs: A. Mantides, E. Tsoukali |
| 12:15-12:30 |
Δίαιτα;/ Diet? |
| 12:30-12:45 |
AAΠ;/ PPIs? |
| 12:45-13:00 |
Τοπικά στεροειδή;/ Locally acting steroids? |
| 13:00-13:15 |
Συνεχής ή επεισοδιακή θεραπεία;/ Continuous or episodic treatment? |
| 13:15 - 14:30 |
Κοιλιοκάκη & Μικροσκοπική Κολίτιδα/ Coeliac disease and microscopic colitis Προεδρείο: Μ. Μελά, A. Χρηστίδου/ Chairs: M. Mela, A. Christidou |
| 13:15-13:30 |
Μιμητές της κοιλιοκάκης/ Coeliac disease mimickers |
| 13:30-13:45 |
Ο διαγνωστικά οριακός ασθενής με τις συνήθεις διαγνωστικές μεθόδους: μπορεί να βοηθήσει η γενετική;/ The diagnostic borderline patient: can genetics help? |
| 13:45-14:00 |
Χρειάζομαι ακόμη ένα διαιτολόγο;/ Do I still need a dietician? |
| 14:00-14:15 |
Μη διαιτητικές θεραπείες: Φως στην άκρη του τούνελ;/ Non dietetic therapies: is there light at the end of the tunnel? |
| 14:15-14:30 |
Μικροσκοπική κολίτιδα: Διαγνωστικοί και Θεραπευτικοί χειρισμοί/ Microscopic colitis: diagnostic and therapeutic interventions |
| 14:15 - 14:30 | Ανασκόπηση - Αποχαιρετισμός/ Review and Farewell |
Organizing - Administrative Bureau/ Secretariat:
Conferre SA: "The Art of Bringing People Together".
- Stavrou Niarchou Ave., Mares Position
GR455 00 Pedini, Ioannina, GREECE - +30 26510 68610
- +30 26510 68611
- info@conferre.gr
ΓΕΜΗ: 31498929000
Certified by ISO 9001:2015
Certificate Number 00.12.0895
Certificate Number 00.12.0895
Αριθμός Αδείας ΕΟΤ
0622E60000012001
0622E60000012001
